Cancer screening in China for foreigners is the part of a checkup where it is easiest to do the wrong thing. Over-screening — testing for everything, at every age, with the most expensive modality — produces anxiety, incidental findings and cascades of unnecessary follow-up. Under-screening — skipping the tests that actually matter at your age — is how a treatable early cancer is missed. This article explains which cancer screenings are worth doing at which ages, how the system works in China, and how to arrange screening as part of a plan rather than a scatter-shot. HealthBridge is a checkup planner: we build the test list around your risk profile and match you to hospitals that can deliver it.
Which screenings actually matter, and at what age
Screening means testing people without symptoms, to find cancer early enough that treatment changes the outcome. Not every cancer is screenable, and not every screenable cancer is worth screening for at every age.
The screenings with clear evidence
Cervical cancer screening — HPV testing and Pap smear — is recommended for women from the early twenties through the sixties, with frequency depending on the method and prior results. Breast cancer screening — mammography, with or without ultrasound — is recommended for women from around age 40, with frequency depending on risk. Colorectal cancer screening — stool test, colonoscopy or sigmoidoscopy — is recommended for adults from age 45 to 75, with the method and frequency depending on risk and preference. Low-dose chest CT is recommended for lung cancer screening in adults aged 50 to 80 with a significant smoking history. These are the screenings with the strongest evidence behind them.
Screenings that depend on your profile
Prostate cancer screening (PSA) is a shared decision after age 50, depending on risk and life expectancy — it is not a blanket recommendation. Liver cancer screening — ultrasound plus AFP — is recommended for people with chronic hepatitis B or C, cirrhosis or other risk factors, not for the general population. Thyroid cancer screening by ultrasound is commonly offered in Chinese checkups, but it is not a routine recommendation for asymptomatic people at average risk, because it produces a high rate of incidental nodules that lead to follow-up without clear benefit. Know why each test is on your list.
What is not screening
Tumour-marker blood panels — a bundle of tests like CEA, AFP, CA19-9, CA125, PSA — are widely included in Chinese checkup packages. They are not recommended for screening of asymptomatic people at average risk, because they produce false positives that lead to unnecessary investigation. They have a role in monitoring known cancer, not in finding it. If your checkup includes a large tumour-marker panel, ask why, and be prepared for a value that is slightly elevated and means nothing. For how this plays out in practice, see our case studies.
How cancer screening works in China
The mechanics are similar to other checkup services, with a few specifics.
Where to go
Cancer screening that involves imaging — mammography, low-dose chest CT, ultrasound — is best done at a hospital with a radiology department that can both acquire and read the images, and with a clear pathway for follow-up if something is found. International departments and major public hospitals fit this. A private imaging centre can acquire images but may not have the follow-up pathway, which is the part that matters when a screening test is positive. For reference on what different facilities cost, see our cost comparison page.
How results are reported
Imaging results in China are typically reported using a structured system — for mammography, the BI-RADS category; for low-dose chest CT, the Lung-RADS or a nodule description; for thyroid ultrasound, the TI-RADS category. These categories tell you the likelihood that a finding is significant and what the next step should be. A good report includes the category, not just a description, and a good hospital explains what it means.
Follow-up pathway
The point of screening is not the test itself but the follow-up if something is found. A nodule, a polyp, an abnormal stool test or a BI-RADS 4 category each has a defined next step: a repeat scan at an interval, a biopsy, a colonoscopy or a referral. Confirm before you screen that the hospital can handle the follow-up, because a finding without a pathway is anxiety without a plan.
How to build a screening plan
A screening plan should be built, not bought off a shelf.
Start with your risk profile
Your age, sex, family history, smoking history, alcohol use, prior screenings and any existing conditions determine which screenings are worth doing. A 45-year-old non-smoker with no family history needs colorectal screening; a 55-year-old smoker needs colorectal and low-dose chest CT; a woman with a family history of breast cancer may need mammography earlier and more frequently. The plan should start from these facts, not from a package menu.
Prioritise the high-value screenings
If budget is a constraint, prioritise the screenings with the strongest evidence for your profile — cervical, breast, colorectal, and low-dose chest CT for smokers. These are the screenings where finding cancer early genuinely changes outcomes. A tumour-marker panel is not a substitute for any of them.
Set the interval
Screening is repeated at intervals that depend on the test, the result and the risk profile. Cervical screening every three to five years; mammography every one to two years; colorectal screening every one to ten years depending on method; low-dose chest CT annually for those who qualify. A plan that does not say when to repeat is incomplete.
What to avoid
Three mistakes account for most of the poor screening decisions foreigners make in China.
Screening for everything
A package that includes every cancer marker, every imaging modality and every scan is not a better plan — it is a more expensive plan with more false positives. Screen for the cancers where screening has evidence, at the age where it matters, and skip the rest.
Skipping the follow-up
A screening test is only useful if the result is acted on. If a finding needs a repeat scan in six months, do it. The number of people who screen, find something, and then do nothing is the reason screening sometimes does not change outcomes.
Using tumour markers as screening
Tumour-marker panels are widely included in Chinese checkups and widely misunderstood. They are not screening tests for asymptomatic people at average risk. A slightly elevated marker usually means nothing, and chasing it leads to unnecessary scans and biopsies. If a marker is elevated, repeat it before imaging, and interpret it with a clinician who understands the limitations.
Screening and travel
If you are travelling to China for screening, the same planning rules apply, plus logistics. Review the medical visa checklist for entry rules, and build in enough time for follow-up if a finding needs it — a few days for a repeat scan, longer for a biopsy or colonoscopy. Screening that finds something and then sends you home without a plan is a bad outcome.
If you want a screening plan built around your risk profile and matched to hospitals in China that can deliver it, send us your situation — age, sex, family history, smoking history, prior screenings and the city you are in — and we will build the list and the shortlist.